Literature DB >> 26954594

Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Kristen A Woodberry1, Daniel I Shapiro, Caitlin Bryant, Larry J Seidman.   

Abstract

LEARNING
OBJECTIVES: After participating in this activity, learners should be better able to: ABSTRACT: The psychosis prodrome, or period of clinical and functional decline leading up to acute psychosis, offers a unique opportunity for identifying mechanisms of psychosis onset and for testing early-intervention strategies. We summarize major findings and emerging directions in prodromal research and provide recommendations for clinicians working with individuals suspected to be at high risk for psychosis. The past two decades of research have led to three major advances. First, tools and criteria have been developed that can reliably identify imminent risk for a psychotic disorder. Second, longitudinal clinical and psychobiological data from large multisite studies are strengthening individual risk assessment and offering insights into potential mechanisms of illness onset. Third, psychosocial and pharmacological interventions are demonstrating promise for delaying or preventing the onset of psychosis in help-seeking, high-risk individuals. The dynamic psychobiological processes implicated in both risk and onset of psychosis, including altered gene expression, cognitive dysfunction, inflammation, gray and white matter brain changes, and vulnerability-stress interactions suggest a wide range of potential treatment targets and strategies. The expansion of resources devoted to early intervention and prodromal research worldwide raises hope for investigating them. Future directions include identifying psychosis-specific risk and resilience factors in children, adolescents, and non-help-seeking community samples, improving study designs to test hypothesized mechanisms of change, and intervening with strategies that, in order to improve functional outcomes, better engage youth, address their environmental contexts, and focus on evidence-based neurodevelopmental targets. Prospective research on putatively prodromal samples has the potential to substantially reshape our understanding of mental illness and our efforts to combat it.

Entities:  

Mesh:

Year:  2016        PMID: 26954594      PMCID: PMC4870599          DOI: 10.1097/HRP.0000000000000109

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  174 in total

1.  Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.

Authors:  Benno G Schimmelmann; Chantal Michel; Alexandra Martz-Irngartinger; Caroline Linder; Frauke Schultze-Lutter
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk.

Authors:  C B Pedersen; P B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2001-11

3.  Increased stress-induced dopamine release in psychosis.

Authors:  Romina Mizrahi; Jean Addington; Pablo M Rusjan; Ivonne Suridjan; Alvina Ng; Isabelle Boileau; Jens C Pruessner; Gary Remington; Sylvain Houle; Alan A Wilson
Journal:  Biol Psychiatry       Date:  2011-11-30       Impact factor: 13.382

Review 4.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature.

Authors:  E F Torrey; J Miller; R Rawlings; R H Yolken
Journal:  Schizophr Res       Date:  1997-11-07       Impact factor: 4.939

5.  The Finnish adoptive family study of schizophrenia. Implications for family research.

Authors:  P Tienari; L C Wynne; J Moring; I Lahti; M Naarala; A Sorri; K E Wahlberg; O Saarento; M Seitamaa; M Kaleva
Journal:  Br J Psychiatry Suppl       Date:  1994-04

6.  Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.

Authors:  Patrick D McGorry; Barnaby Nelson; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Annette Thampi; Gregor E Berger; G Paul Amminger; Magenta B Simmons; Daniel Kelly; Grad Dip; Andrew D Thompson; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2012-11-27       Impact factor: 4.384

7.  Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.

Authors:  Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-01-12       Impact factor: 4.939

8.  Genotype-environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees.

Authors:  Pekka Tienari; Lyman C Wynne; Anneli Sorri; Ilpo Lahti; Kristian Läksy; Juha Moring; Mikko Naarala; Pentti Nieminen; Karl-Erik Wahlberg
Journal:  Br J Psychiatry       Date:  2004-03       Impact factor: 9.319

Review 9.  Development of social functioning in preschizophrenia children and adolescents: a systematic review.

Authors:  Sarah I Tarbox; Michael F Pogue-Geile
Journal:  Psychol Bull       Date:  2008-07       Impact factor: 17.737

10.  Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies.

Authors:  L J Seidman; S Cherkerzian; J M Goldstein; J Agnew-Blais; M T Tsuang; S L Buka
Journal:  Psychol Med       Date:  2012-05-11       Impact factor: 7.723

View more
  15 in total

1.  An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).

Authors:  M Friedman-Yakoobian; E M Parrish; A Thomas; R Lesser; A Gnong-Granato; S Eack; M S Keshavan
Journal:  Schizophr Res       Date:  2019-02-05       Impact factor: 4.939

2.  Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort.

Authors:  Kristen A Woodberry; Larry J Seidman; Caitlin Bryant; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods
Journal:  J Clin Child Adolesc Psychol       Date:  2016-10-05

3.  Emotional and stigma-related experiences relative to being told one is at risk for psychosis.

Authors:  Kristen A Woodberry; Kate S Powers; Caitlin Bryant; Donna Downing; Mary B Verdi; Katherine M Elacqua; Audrey R L Reuman; Leda Kennedy; Daniel I Shapiro; Michelle L West; Debbie Huang; Francesca M Crump; Margaux M Grivel; Drew Blasco; Shaynna N Herrera; Cheryl M Corcoran; Larry J Seidman; Bruce G Link; William R McFarlane; Lawrence H Yang
Journal:  Schizophr Res       Date:  2021-09-28       Impact factor: 4.662

4.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

5.  Development of a Boston Treatment Program for Youth at Clinical High Risk for Psychosis: Center for Early Detection, Assessment, and Response to Risk (CEDAR).

Authors:  Michelle S Friedman-Yakoobian; Michelle L West; Kristen A Woodberry; Keira E O'Donovan; Suzannah V Zimmet; Andréa Gnong-Granato; Anthony J Giuliano; Margaret E Guyer; Janine Rodenhiser-Hill; Matcheri S Keshavan; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

6.  Development of a probability calculator for psychosis risk in children, adolescents, and young adults.

Authors:  Tyler M Moore; Monica E Calkins; Adon F G Rosen; Ellyn R Butler; Kosha Ruparel; Paolo Fusar-Poli; Nikolaos Koutsouleris; Philip McGuire; Tyrone D Cannon; Ruben C Gur; Raquel E Gur
Journal:  Psychol Med       Date:  2021-01-12       Impact factor: 10.592

7.  Computer-aided learning for managing stress: A feasibility trial with clinical high risk adolescents and young adults.

Authors:  Kristen A Woodberry; Cole Chokran; Kelsey A Johnson; Keith H Nuechterlein; David J Miklowitz; Stephen V Faraone; Larry J Seidman
Journal:  Early Interv Psychiatry       Date:  2020-04-01       Impact factor: 2.721

8.  Symptom trajectories into eating disorders: A systematic review of longitudinal, nonclinical studies in children/adolescents.

Authors:  Jessica McClelland; Lauren Robinson; Rachel Potterton; Victoria Mountford; Ulrike Schmidt
Journal:  Eur Psychiatry       Date:  2020-05-26       Impact factor: 5.361

Review 9.  Verbal memory measurement towards digital perspectives in first-episode psychosis: A review.

Authors:  Can Mişel Kilciksiz; Richard Keefe; James Benoit; Dost Öngür; John Torous
Journal:  Schizophr Res Cogn       Date:  2020-04-15

10.  Identifying and treating the prodromal phases of bipolar disorder and schizophrenia.

Authors:  Susan Conroy; Michael Francis; Leslie A Hulvershorn
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.